Corbus Pharmaceuticals Holdings, Inc.·4

May 29, 4:11 PM ET

Panayiotopoulos Paris 4

4 · Corbus Pharmaceuticals Holdings, Inc. · Filed May 29, 2018

Insider Transaction Report

Form 4
Period: 2018-05-24
Transactions
  • Award

    Stock Option(right to buy)

    2018-05-24+34,00034,000 total
    Exercise: $5.93Exp: 2028-05-24Common Stock (34,000 underlying)
Footnotes (1)
  • [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION